ArticleOncology letters2022

Long-term remission under Disitamab Vedotin (RC48) in HR-positive/HER2-positive metastatic breast cancer with brain meningeal, and bone marrow involvement: A case report.

Qifeng Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.